MedPath

IMPRESSeD: IMproving facial PRosthesis construction with contactlESs Scanning and Digital workflow

Not Applicable
Conditions
Facial defect following surgery for head or neck cancer. The trial management group may also widen participation to participants with facial trauma.
Cancer
Malignant neoplasm of head, face, and neck
Registration Number
ISRCTN10516986
Lead Sponsor
niversity of Leeds
Brief Summary

2023 Protocol article in https://pubmed.ncbi.nlm.nih.gov/37400919/ (added 04/07/2023)

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
All
Target Recruitment
30
Inclusion Criteria

1. Acquired orbital or nasal facial defects
2. Require a replacement orbital or nasal facial prosthesis
3. Capable of giving informed consent
4. Available for follow-up
5. Aged =16 years

Exclusion Criteria

1. Receiving active cancer therapy or have plans for major reconstructive surgery
2. Have not received a removable facial prosthesis previously
3. Facial defects due to an underlying congenital aetiology
4. Known hypersensitivity to the materials used in the research
5. Pre-existing skin conditions that require intervention and prevent the delivery of a new prosthesis
6. Unable to give informed consent

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<br> 1. Eligibility rate measured as the proportion of people that were approached who were eligible for participation at baseline<br> 2. Recruitment rate measured as the proportion of people that were invited that were successfully recruited at baseline<br> 3. Conversion rate measured as the proportion of those who were eligible that consented to participate at baseline<br> 4. Attrition rate measured as the proportion of those that dropped out of the trial at 4-week review following delivery of the second prosthesis<br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath